Affinity Selection–Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor
Scott S. Walker(Merck & Co., Inc., Rahway, NJ, USA (United States)), Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xinwei Sher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Donna Carr(Merck & Co., Inc., Rahway, NJ, USA (United States)), David Degen(Rutgers, The State University of New Jersey), Mihir Mandal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elliott Nickbarg(Merck & Co., Inc., Rahway, NJ, USA (United States)), Richard H. Ebright(Rutgers Sexual and Reproductive Health and Rights), Li Xiao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jing Su(Merck & Co., Inc., Rahway, NJ, USA (United States)), Aileen Soriano(Merck & Co., Inc., Rahway, NJ, USA (United States)), David B. Olsen, Payal R. Sheth(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ronald E. Painter(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 17
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272